Efficacy of fluticasone furoate nasal spray vs. placebo for the treatment of ocular and nasal symptoms of allergic rhinitis: A systematic review

Clinical and Experimental Allergy

Volumn 41, Issue 2, 2011, Pages 160-170

  Rodrigo, G J ^a   Neffen, H ^b  

^a HOSPITAL CENTRAL DE LAS FUERZAS ARMADAS   (Uruguay)

^b 'O Alassia' Children's Hospital   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

FLUTICASONE FUROATE; PLACEBO;

ALLERGIC RHINITIS; COMPARATIVE STUDY; DRUG EFFICACY; DRUG FEVER; DRUG SAFETY; DRUG WITHDRAWAL; ELECTROCARDIOGRAM; EPISTAXIS; EYE BURNING; EYE DISEASE; EYE REDNESS; EYE TEARING; HUMAN; HYDROCORTISONE BLOOD LEVEL; INSTANTANEOUS TOTAL OCULAR SYMPTOM SCORE; LACRIMATION DISORDER; META ANALYSIS (TOPIC); NASAL PRURITUS; NOSE CONGESTION; NOSE DISEASE; OCULAR PRURITUS; OUTCOME ASSESSMENT; PERENNIAL RHINITIS; PRIORITY JOURNAL; QUALITY OF LIFE; REFLECTIVE TOTAL OCULAR SYMPTOM SCORE; REVIEW; RHINOPHARYNGITIS; RHINORRHEA; SCORING SYSTEM; SEASONAL VARIATION; SIDE EFFECT; SNEEZING; SYSTEMATIC REVIEW; VITAL SIGN;

ADMINISTRATION, INTRANASAL; ANDROSTADIENES; ANTI-ALLERGIC AGENTS; HUMANS; NASAL SPRAYS; PLACEBOS; RHINITIS, ALLERGIC, SEASONAL;

EID: 78651423306     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2010.03654.x     Document Type: Review

References (41)

1. Bousquet J, Khaltaev N, Cruz AA et al. Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA LEN and AllerGen). Allergy 2008; 63:8-160.
2. Canonica GW, Bousquet J, Mullol J, Scadding JK, Virchow JC. A survey of the burden of allergic rhinitis in Europe. Allergy 2007; 62 (Suppl 85):17-25.
3. Ciprandi G, Cirillo I, Vizzaccaro A et al. Seasonal and perennial allergic rhinitis: is this classification adherent to real life? Allergy 2005; 60:882-7.
4. Brozek JL, Bousquet J, Baena-Cagnani CE et al. Allergic rhinitis and its impact on asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol 2010; 126:466-7.
5. Weiner JM, Abramson MJ, Puy RM. Intranasal corticosteroids vs. oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials. BMJ 1998; 317:1624-9.
6. Yañez A, Rodrigo GJ. Intranasal corticosteroids vs. topical H1 receptor antagonists for the treatment of allergic rhinitis: a systematic review with meta-analysis. Ann Allergy Asthma Immunol 2002; 89:479-84.
7. Rodrigo GJ, Yañez A. the role of antileukotriene therapy in allergic rhinitis: a systematic review of randomized trials. Ann Allergy Asthma Immunol 2006; 96:779-86.
8. Wilson AM, O'Byrne PM, Parameswaran K. Leukotriene receptor antagonists for allergic rhinitis: a systematic review and meta-analysis. Am J Med 2004; 116:338-44.
9. Wallace DV, Dykewicz MS, Bernstein DI et al. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol 2008; 122:S1-84.
10. Keith PK, Scadding GK. Are intranasal corticosteroids all equally consistent in managing ocular symptoms of seasonal allergic rhinitis? Curr Med Res Opin 2009; 25:2021-4.
11. Scadding GK, Keith PK. Fluticasone furoate nasal spray consistently and significantly improves both the nasal and ocular symptoms of seasonal allergic rhinitis: a review of the clinical data. Expert Opin Pharmacother 2008; 9:2707-15.
12. Kariyawasam HH, Scadding GK. Seasonal allergic rhinitis: fluticasone propionate and fluticasone furoate therapy evaluated. J Asthma Allergy 2010; 3:17-26.
13. Juniper EF, Guyatt GH. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy 1991; 21:77-83.
14. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. Clinical safety data management: Definitions and standards for expedited reporting. Available at: Accessed June 24, 2010.
15. Liberati A, Altman DG, Tetzlaff J et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 2009; 151:W1-30.
16. Higgins JPT, Green S editors. Cochrane Handbook for Systematic Reviews of Interventions 5.0.2 [updated September 2009]. Available at: Accessed June 24, 2010.
17. Higgins JPT, Thompson SG, Deecks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327:557-60.
18. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. Introduction to meta-analysis. Chichester (West Sussex): John Wiley & Songs, Ltd, 2009.
19. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315:629-34.
20. Altman DG, Bland JM. Interaction revisited: the difference between two estimates. BMJ 2003; 326:219.
21. Fokkens WJ, Jogi R, Reinartz S et al. Once daily fluticasone furoate nasal spray is effective in seasonal allergic rhinitis caused by grass pollen. Allergy 2007; 62:1078-84.
22. Kaiser HB, Naclerio RM, Given J, Toler TN, Ellsworth A, Philpot EE. Fluticasone furoate nasal spray: a single treatment option for the symptoms of seasonal allergic rhinitis. J Allergy Clin Immunol 2007; 119:1430-7.
23. Martin BG, Ratner PH, Hampel FC et al. Optimal dose selection of fluticasone furoate nasal spray for the treatment of seasonal allergic rhinitis in adults and adolescents. Allergy Asthma Proc 2007; 28:216-25.
24. Andrews CP, Martin BG, Jacobs RL et al. Fluticasone furoate nasal spray is more effective than fexofenadine for nighttime symptoms of seasonal allergy. Allergy Asthma Proc 2009; 30:128-3.
25. Jacobs R, Martin B, Hampel F, Tolerd W, Ellsworth A, Philpot E. Effectiveness of fluticasone furoate 110 mg once daily in the treatment of nasal and ocular symptoms of seasonal allergic rhinitis in adults and adolescents sensitized to mountain cedar pollen. Curr Med Res Opin 2009; 25:1393-401.
26. Meltzer EO, Lee J, Tripathy I, Lim J, Ellsworth A, Philpot E. Efficacy and safety of once-daily fluticasone furoate nasal spray in children with seasonal allergic rhinitis treated for 2 wk. Pediatr Allergy Immunol 2009; 20:279-86.
27. Rosenblut A, Bardin PG, Muller B et al. Long-term safety of fluticasone furoate nasal spray in adults and adolescents with perennial allergic rhinitis. Allergy 2007; 62:1071-7.
28. Máspero JF, Rosenblut A, Finn A, Lim L, Wu W, Philpot E. Safety and efficacy of fluticasone furoate in pediatric patients with perennial allergic rhinitis. Otolaryngol-Head Neck Surg 2008; 138:30-7.
29. Nathan RA, Berger W, Yang W et al. Effect of once-daily fluticasone furoate nasal spray on nasal symptoms in adults and adolescents with perennial allergic rhinitis. Ann Allergy Asthma Immunol 2008; 100:497-505.
30. Patel D, Ratner P, Clements D, Wu W, Faris M, Philpot E. Lack of effect on adult and adolescent hypothalamic-pituitary-adrenal axis function with use of fluticasone furoate nasal spray. Ann Allergy Asthma Immunol 2008; 100:490-6.
31. Vasar M, Houle PA, Meltzer EO et al. Fluticasone furoate nasal spray: effective monotherapy for symptoms of perennial allergic rhinitis in adults/adolescents. Allergy Asthma Proc 2008; 29:313-21.
32. Tripathy I, Levy A, Ratner P, Clements D, Wu W, Philpot E. HPA axis safety of fluticasone furoate nasal spray once daily in children with perennial allergic rhinitis. Pediatr Allergy Immunol 2009; 20:287-94.
33. GlaxoSmithKline. Trial number FFR100650. Available at: (Accessed 26 June 2010).
34. GlaxoSmithKline. Trial number FFR100652. Available at: Accessed June 26, 2010.
35. GlaxoSmithKline. Trial number FFR111439. Available at: Accessed June 26, 2010.
36. Bernstein DI, Levy AL, Hampel FC et al. Treatment with intranasal fluticasone propionate significantly improves ocular symptoms in patients with seasonal allergic rhinitis. Clin Exp Allergy 2004; 34:952-7.
37. Bielory L. Ocular symptom reduction in patients with seasonal rhinitis treated with the intranasal corticosteroid mometasone fuorate. Ann Allergy Asthma Immunol 2008; 100:272-9.
38. Prenner BM, Lanier BQ, Bernstein DI, Shekar T, Teper A. Mometasone furoate nasal spray reduces the ocular symptoms of seasonal allergic rhinitis. J Allergy Clin Immunol 2010; 125:1247-53.
39. Bielory L. Intranasal corticosteroids reduce ocular symptoms of allergic rhinitis as a class effect. J Allergy Clin Immunol 2008; 121:538-9.
40. Naclerio RM, Pinto J, deTineo M, Baroody FM. Elucidating the mechanism underlying the ocular symptoms associated with allergic rhinitis. Allergy Asthma Proc 2008; 29:24-8.
41. Juniper EF, Guyatt GH, Griffith LE, Ferrie PJ. Interpretation of rhinoconjunctivitis quality of life questionnaire data. J Allergy Clin Immunol 1996; 98:843-5.